Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
ASND Ascendis Pharma A/S	$177.20 +1.0%	$169.23	$111.09 ▼ $183.00	$10.72B	0.38	505,404 shs	353,205 shs
BRO Brown & Brown	$104.23 -0.7%	$109.20	$92.29 ▼ $125.68	$30.09B	0.82	1.92 million shs	3.34 million shs
GRI GRI Bio	$1.95 -5.8%	$1.44	$1.10 ▼ $43.69	$5.17M	-1.62	146,453 shs	246,928 shs
IZN InZinc Mining	C$0.02 -20.0%	C$0.02	C$0.02 ▼ C$0.03	C$2.47M	3.76	80,855 shs	2,000 shs

7 Stocks to Buy And Hold Forever

Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
ASND Ascendis Pharma A/S	+1.03%	+0.40%	+2.49%	+7.36%	+27.88%
BRO Brown & Brown	-0.68%	-3.26%	-3.50%	-11.05%	+11.36%
GRI GRI Bio	-5.80%	+23.42%	+43.38%	+29.14%	-93.37%
IZN InZinc Mining	0.00%	-20.00%	-20.00%	0.00%	-20.00%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
ASND Ascendis Pharma A/S	3.7326 of 5 stars	4.5	3.0	0.0	0.0	3.5	1.7	0.6
BRO Brown & Brown	4.314 of 5 stars	3.2	3.0	1.7	2.5	1.8	2.5	1.3
GRI GRI Bio	3.0509 of 5 stars	3.5	4.0	0.0	0.0	3.0	0.0	1.3
IZN InZinc Mining	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
ASND Ascendis Pharma A/S	3.00	Buy	$223.07	25.88% Upside
BRO Brown & Brown	2.43	Hold	$118.23	13.44% Upside
GRI GRI Bio	3.00	Buy	$22.00	1,028.21% Upside
IZN InZinc Mining	0.00	N/A	N/A	N/A

Current Analyst Ratings Breakdown

Latest IZN, BRO, GRI, and ASND Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
7/11/2025	ASND Ascendis Pharma A/S	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Buy ➝ Buy	$213.00 ➝ $243.00
7/9/2025	BRO Brown & Brown	Keefe, Bruyette & Woods Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Underperform ➝ Underperform	$102.00 ➝ $104.00
7/7/2025	BRO Brown & Brown	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Equal Weight ➝ Equal Weight	$121.00 ➝ $111.00
7/3/2025	ASND Ascendis Pharma A/S	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Overweight	$250.00
6/13/2025	ASND Ascendis Pharma A/S	Oppenheimer Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Outperform ➝ Outperform	$215.00 ➝ $224.00
6/13/2025	BRO Brown & Brown	Keefe, Bruyette & Woods Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Underperform ➝ Underperform	$100.00 ➝ $102.00
6/12/2025	BRO Brown & Brown	BMO Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Outperform ➝ Outperform	$116.00 ➝ $122.00
6/12/2025	BRO Brown & Brown	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Overweight ➝ Overweight	$125.00 ➝ $127.00
6/11/2025	GRI GRI Bio	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy
6/9/2025	ASND Ascendis Pharma A/S	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Buy ➝ Buy	$201.00 ➝ $216.00
6/3/2025	ASND Ascendis Pharma A/S	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Buy ➝ Buy	$196.00 ➝ $201.00

(Data available from 7/18/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
ASND Ascendis Pharma A/S	$393.54M	27.53	N/A	N/A	($1.88) per share	-94.26
BRO Brown & Brown	$4.81B	6.22	$4.49 per share	23.20	$22.51 per share	4.63
GRI GRI Bio	N/A	N/A	N/A	N/A	$7.68 per share	N/A
IZN InZinc Mining	N/A	N/A	C$0.02 per share	1.20	C$0.02 per share	N/A

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
ASND Ascendis Pharma A/S	-$409.12M	-$6.28	N/A	738.33	N/A	-93.22%	N/A	-33.29%	9/2/2025 (Estimated)
BRO Brown & Brown	$993M	$3.59	29.03	22.96	2.30	20.84%	17.77%	6.76%	7/28/2025 (Estimated)
GRI GRI Bio	-$8.21M	-$11.56	N/A	N/A	N/A	N/A	-275.15%	-168.22%	8/12/2025 (Estimated)
IZN InZinc Mining	-C$1.28M	N/A	2.00	∞	N/A	N/A	-16.50%	-9.89%	N/A

Latest IZN, BRO, GRI, and ASND Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/12/2025	Q2 2025	GRI GRI Bio	-$1.31	N/A	N/A	N/A	N/A	N/A
7/28/2025	Q2 2025	BRO Brown & Brown	$0.99	N/A	N/A	N/A	$1.28 billion	N/A
5/15/2025	Q1 2025	GRI GRI Bio	-$4.08	-$5.80	-$1.72	-$5.80	N/A	N/A
5/1/2025	Q1 2025	ASND Ascendis Pharma A/S	-$1.56	-$1.66	-$0.10	-$1.66	$98.56 million	$123.97 million
4/28/2025	Q1 2025	BRO Brown & Brown	$1.30	$1.29	-$0.01	$1.15	$1.41 billion	$1.40 billion

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
ASND Ascendis Pharma A/S	N/A	N/A	N/A	N/A	N/A
BRO Brown & Brown	$0.60	0.58%	N/A	16.71%	N/A
GRI GRI Bio	N/A	N/A	N/A	N/A	N/A
IZN InZinc Mining	N/A	N/A	N/A	N/A	N/A

Latest IZN, BRO, GRI, and ASND Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
4/28/2025	BRO Brown & Brown	quarterly	$0.15	0.52%	5/12/2025	5/12/2025	5/21/2025

(Data available from 1/1/2013 forward)

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
ASND Ascendis Pharma A/S	N/A	1.04	0.71
BRO Brown & Brown	0.55	2.52	2.52
GRI GRI Bio	N/A	1.41	1.41
IZN InZinc Mining	N/A	26.59	24.92

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
ASND Ascendis Pharma A/S	N/A
BRO Brown & Brown	71.01%
GRI GRI Bio	33.95%
IZN InZinc Mining	3.24%

Insider Ownership

Company	Insider Ownership
ASND Ascendis Pharma A/S	40.00%
BRO Brown & Brown	17.02%
GRI GRI Bio	0.13%
IZN InZinc Mining	20.14%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
ASND Ascendis Pharma A/S	1,017	61.13 million	36.68 million	Optionable
BRO Brown & Brown	17,403	286.68 million	237.89 million	Optionable
GRI GRI Bio	1	2.50 million	2.49 million	Not Optionable
IZN InZinc Mining	N/A	123.40 million	N/A	Not Optionable

IZN, BRO, GRI, and ASND Headlines

Recent News About These Companies

InZinc Mobilizes to Drill Test for Extensions to Sedex Zn-Pb-Ag Discovery at Indy Project, Central BC

May 29, 2025 | finance.yahoo.com

InZinc Mining Mobilizes to Drill Test for Extensions to Sedex Zn-Pb-Ag Discovery at Indy Project, Central BC

May 29, 2025 | juniorminingnetwork.com

InZinc Mining Initiates Drilling to Expand Indy Sedex Project

May 29, 2025 | tipranks.com

IZN:CA InZinc Mining Ltd.

April 17, 2025 | seekingalpha.com

InZinc Prepares for 2025 Drill Program at Indy Project in Central BC

April 15, 2025 | goldseiten.de

InZinc Mining Ltd. Prepares for 2025 Drill Program at Indy Project in Central BC

April 15, 2025 | goldseiten.de

InZinc Mining Discovers New Anomaly Supporting Extension of Near Surface Mineralization at Indy Sedex Project, Central BC

February 24, 2025 | juniorminingnetwork.com

InZinc Discovers New Anomaly Supporting Extension of Near Surface Mineralization at Indy Sedex Project, Central BC

February 24, 2025 | finance.yahoo.com

InZinc Mining Unveils New Anomaly at Indy Project, Signaling Expansion Potential

February 24, 2025 | tipranks.com

Oil prices fall 2% on economic worries, technical decline

August 29, 2024 | ca.finance.yahoo.com

Sony hikes the PlayStation 5 price in Japan by 19 percent

August 29, 2024 | ca.finance.yahoo.com

InZinc Mining Continues to Advance New Large-Scale Sedex Zn-Pb-Ag Targets at Indy Project, Central BC

August 29, 2024 | juniorminingnetwork.com

InZinc Continues to Advance New Large-Scale Sedex Zn-Pb-Ag Targets at Indy Project, Central BC

August 27, 2024 | msn.com

InZinc Receives 5-Year Drill Permit Renewal and Provides Exploration Update at Indy Project in Central BC

July 26, 2024 | finance.yahoo.com

InZinc Mining Receives 5-Year Drill Permit Renewal and Provides Exploration Update at Indy Project in Central BC

July 26, 2024 | juniorminingnetwork.com

Closing Bell: Inzinc Mining Ltd flat on Monday (IZN)

May 27, 2024 | theglobeandmail.com

Canadian Investment Regulatory Organization Trade Resumption - IZN

May 16, 2024 | ca.finance.yahoo.com

InZinc Announces Key Correlations to One of the World's Most Prolific Zinc-Lead-Silver Belts, the Selwyn Basin, at the Indy Project in Central BC

May 16, 2024 | stockhouse.com

InZinc Reports Exceptional Barite Intersections at Indy - Planning for Upcoming Exploration

May 2, 2024 | stockhouse.com

InZinc Mining Reports High Grade Barite and Extends Barite Trend to 700 m Strike Length

April 17, 2024 | juniorminingnetwork.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

3 Semiconductor Stocks Poised to Surge on AI Spending
By Chris Markoch | June 25, 2025
View 3 Semiconductor Stocks Poised to Surge on AI Spending
3 Notable Stocks Just Split: Which One Could Be the Big Winner?
By Leo Miller | June 26, 2025
View 3 Notable Stocks Just Split: Which One Could Be the Big Winner?
New All-Time Highs Coming for Broadcom? Wall Street Says Yes
By Leo Miller | June 20, 2025
View New All-Time Highs Coming for Broadcom? Wall Street Says Yes
These 3 Dividend Stocks Combine Strong Yields With Upside
By Chris Markoch | June 20, 2025
View These 3 Dividend Stocks Combine Strong Yields With Upside
Pelosi Makes Big Bet on Broadcom—Here’s Why It Matters
By Gabriel Osorio-Mazilli | July 15, 2025
View Pelosi Makes Big Bet on Broadcom—Here’s Why It Matters

IZN, BRO, GRI, and ASND Company Descriptions

Ascendis Pharma A/S NASDAQ:ASND

$177.20 +1.80 (+1.03%)

Closing price 07/17/2025 04:00 PM Eastern

Extended Trading

$177.09 -0.11 (-0.06%)

As of 07/17/2025 04:14 PM Eastern

Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapies for unmet medical needs. It offers SKYTROFA for treating patients with growth hormone deficiency (GHD). The company is also developing a pipeline of three independent endocrinology rare disease product candidates in clinical development, as well as focuses on advancing oncology therapeutic candidates. The company was incorporated in 2006 and is headquartered in Hellerup, Denmark.

Brown & Brown NYSE:BRO

$104.23 -0.74 (-0.71%)

Closing price 07/17/2025 03:59 PM Eastern

Extended Trading

$104.48 +0.26 (+0.25%)

As of 07/17/2025 05:37 PM Eastern

Brown & Brown, Inc. is an insurance agency, wholesale brokerage, insurance program and service organization. It engages in the provision of insurance brokerage services and casualty insurance underwriting services. It operates through the following segments: Retail, National Programs, Wholesale Brokerage, and Services. The Retail Segment receives fees in lieu of commissions. The National Programs segment acts as a managing general agent and provides professional liability and related package products for certain professionals, a range of insurance products for individuals, flood coverage, and targeted products and services designated for specific industries, trade groups, governmental entities and market niches. The Wholesale Brokerage segment markets and sells excess and surplus commercial and personal lines insurance, primarily through independent agents and brokers, as well as the company’s retail agents. The Services segment provides insurance-related services, including third-party claims administration and comprehensive medical utilization management services in both the workers' compensation and all-lines liability arenas, as well as Medicare Set-aside services, social security disability and Medicare benefits advocacy services and claims adjusting services. The company was founded by J. Adrian Brown and Charles Covington Owen in 1939 and is headquartered in Daytona Beach, FL.

GRI Bio NASDAQ:GRI

$1.95 -0.12 (-5.80%)

As of 07/17/2025 04:00 PM Eastern

GRI Bio, Inc., a clinical-stage biopharmaceutical company, focuses on treating inflammatory, fibrotic, and autoimmune diseases in the United States. Its product pipeline comprises GRI-0621, which is in phase II clinical development for the treatment of idiopathic pulmonary fibrosis; GRI-0803 which is in phase I trial for the treatment of systematic lupus erythematosus; GRI-0124, which is in pre-clinical development for the treatment of primary sclerosing cholangitis; and GRI-0729 in pre-clinical development. The company also develops ADAIR and ADMIR for treatment of attention -deficit/hyperactivity disorder. GRI Bio, Inc. was formerly known as Glycoregimmune, Inc. GRI Bio, Inc. was founded in 2009 and is based in LA Jolla, California.

InZinc Mining CVE:IZN

C$0.02 -0.01 (-20.00%)

As of 07/15/2025 02:10 PM Eastern

InZinc Mining Ltd. acquires, explores for, and develops mineral properties in the United States and Canada. It primarily explores for zinc, copper, and indium deposits. The company holds a 100% interest in the Indy project comprising an area of 19,000 hectares located in Central British Colombia; and the West Desert Property located in Utah, the United States. The company was formerly known as Lithic Resources Ltd. and changed its name to InZinc Mining Ltd. in February 2014. InZinc Mining Ltd. was incorporated in 1997 and is headquartered in Vancouver, Canada.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time